CEO Eric M. Green announces retirement plans from West Pharmaceutical Services.
- Eric M. Green plans to retire by June 2024
- West Pharmaceutical Services will undergo leadership adjustments
- New leadership will ensure continued growth
Eric M. Green, the President and Chief Executive Officer of West Pharmaceutical Services, Inc., has announced his plans to retire from his positions and as Chair of the Board effective June 2024. This decision marks a significant leadership change for the company, which specializes in developing manufacturing solutions for drugs and biologics. Green’s tenure has seen the company navigate a period of growth and innovation.
During his time at West Pharmaceutical Services, Green has played a critical role in enhancing operations and advancing the company’s strategic goals. The Board of Directors will begin the process of identifying a successor to ensure a seamless transition and maintain the ongoing momentum of the company’s initiatives. This leadership change will pave the way for new opportunities in alignment with the company's future objectives.
Green has been instrumental in fostering a culture of innovation and dedication within the organization. His retirement will be followed by a careful succession plan, allowing West Pharmaceutical Services to continue its commitment to quality and service in the pharmaceutical industry. Further details regarding the succession plan and future leadership will be communicated to stakeholders in the coming months.
